In silico screening and experimental validation identify riboflavin as an RNA-targeted antiviral against SARS-CoV-2.
Saved in:
| Title: | In silico screening and experimental validation identify riboflavin as an RNA-targeted antiviral against SARS-CoV-2. |
|---|---|
| Authors: | Jeong, Chae-Hong1 (AUTHOR), Na, Yoo Jin1 (AUTHOR), Kim, Tae Yong1 (AUTHOR), Lee, So Young1 (AUTHOR), Kim, Jungyeon1 (AUTHOR), Ryou, Sangmi1 (AUTHOR) ryousang@korea.kr |
| Source: | Scientific Reports. 8/22/2025, Vol. 15 Issue 1, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
